Assessment of stable ischemic heart disease

References

• Frye RL, Higgins MW, Beller GA, et al. Task Force III: major demographic and epidemiologic trends affecting adult cardiology. J Am Coll Cardiol 1988: 12(3): 840–6
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Squires KW, Gau GT. Prevention of cardiovascular disease: of what value are risk factor modification, exercise, fish consumption, and aspirin therapy? Postgrad Med 1987: 81(5): 52–72
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Gau GT, Squires RW, et al. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mavo Clin Proc 1988: 63(6): 605–21
   PubMed Web of Science ®Google Scholar
• O'Keefe JH Jr, Lavie CJ, O'Keefe JO. Dietary prevention of coronary artery disease: how to help patients modify eating habits and reduce cholesterol. Postgrad Med 1989: 85(6): 243–61
   PubMed Web of Science ®Google Scholar
• Lavie CJ, O'Keefe JH, Blonde L, et al. High-density lipoprotein cholesterol: recommendations for routine testing and treatment. Postgrad Med 1990: 87(7): 36–51
   PubMed Web of Science ®Google Scholar
• Lavie CJ Jr, Nunez BD, Garavaglia GE, et al. Hypertensive concentric left ventricular hypertrophy: when is ventricular ectopic activity increased? South Med J 1988: 81 (6): 696–700
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest 1986: 90(2): 275–9
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Ventura HO, Messerli FH. Regression of hypertensive left ventricular hypertrophy. Drugs (in press)
   Google Scholar
• Lavie CJ, Squires RW, Gau GT. Preventive cardiology: what is the value of antiplatelet agents and fish oil's? South Med J 1988: 81(9): 1145–50
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Genton E. Hemostasis, thrombosis, and antiplatelet therapy: implication for the prevention of cardiovascular diseases. Cardiovasc Rev Reports (in press)
   Google Scholar
• Campeau L, Hnjalbert M, Lespérance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Engl J Med 1984: 311 (21): 1329–32
   PubMed Web of Science ®Google Scholar
• Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986: 256(20): 2835–8
   PubMed Web of Science ®Google Scholar
• Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risks of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986: 256(20): 2823–8
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Khandheria BK, Ballard D, et al. Diabetes and cardiovascular disease. In: Bergman M, Sicard G, eds. Surgical management of the diabetic patient. New York: Raven Press (in press)
   Google Scholar
• Gibbons RJ. Noninvasive exercise testing in cardiac disease. In: Spittell JA Jr, ed. Clinical medicine. Vol 6. Chap 4. New York: HarperCollins, 1985: 1–31
   Google Scholar
• Epstein SE. Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease: role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging. Am J Cardiol 1980: 46(Sep): 491–9
   PubMed Web of Science ®Google Scholar
• Schlant RC, Blomvqist CG, Brandenburg RO, et al. Guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association on Assessment of Cardiovascular Procedures (Subcommittee on Exercise Testing). J Am Coll Cardiol 1986: 8(3): 725–38
   PubMedGoogle Scholar
• Kligfield P, Ameisen O, Okin PM. Heart rate adjustment of ST segment depression for improved detection of coronary artery disease. Circulation 1989: 79(2): 245–55
   PubMed Web of Science ®Google Scholar
• Okin PM, Kligfidd P, Milner MR, et al. Heart rate adjustment of ST-segment depression for reduction of fake positive electrocardiographic responses to exercise in asymptomatic men screened for coronary artery disease. Am J Cardiol 1988: 62(Nov 15): 1043–7
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Oh JK, Mankin HT, et al. Significance of T-wave pseudonormalization during exercise: a radionuclide angiographic study. Chest 1988: 94(3): 512–6 [erratum, Chest 1989: 95(1): 252]
   PubMed Web of Science ®Google Scholar
• Marin JJ, Heng MK, Sevrin R, et al. Significance of T wave normalization in the electrocardiogram during exercise stress test. Am Heart J 1987: 114(6): 1342–8
   PubMed Web of Science ®Google Scholar
• Weiner DA, Ryan TJ, McCabe CH, et al. Comparison of coronary artery bypass surgery and medical therapy in patients with exercise-induced silent myocardial ischemia: a report fiom the Coronary Artery Surgery Study (CASS) registry. J Am Coll Cardiol 1988: 12(3): 595–9
   PubMed Web of Science ®Google Scholar
• Gibbons RJ, Fyke FE 3d, Clements IP, et al. Noninvasive identification of severe coronary artery disease using exercise radionuclide angiography. J Am Coll Cardiol 1988: 11(1): 28–34
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Gibbons RJ, Zinsmiester AR, et al. Interpreting results of exercise studies after acute myocardial infarction altered by thrombolytic therapy, coronary angioplasty, or bypass. Am J Cardiol (in press)
   Google Scholar
• Kaul S, Lilly DR, Gascho JA, et al. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation 1988: 77(4): 745–8
   PubMed Web of Science ®Google Scholar
• Kaul S, Finkelstein DM, Homma S, et al. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol 1988: 12(1): 25–34
   PubMed Web of Science ®Google Scholar
• Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989: 110(11): 859–66
   PubMed Web of Science ®Google Scholar
• Lapeyre AC, Gibbons RJ, Forstrom LA. Prediction of cardiac complications of non-cardiac surgery by intravenous dipyridamole thallium tomography. (Abstr) J Nucl Med 1988: 29: 838
   Google Scholar
• Spittell PC, Gibbons RJ. ECG changes during dipyridamole infusion are a marker for severe coronary disease. (Abstr) Circulation 1989: 80(Suppl II): II–247
   Google Scholar
• Ron J Jr, Brandenburg RO, Dinsmore RE, et al. Guidelines for coronary angiography: a report of the American College of Cardiology/American Hean Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures 1987: 10(4): 935–50
   Google Scholar